This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
Login or create an account to see restricted content
Login or Register- AT2D Slide library
- Therapeutic Management
- Patient case study - Patient with acute myocardial infarction
Patient case study - Patient with acute myocardial infarction
This interactive module explores the care of a patient whose T2D was diagnosed after an acute myocardial infarction. Further management of T2D after hospital discharge is also discussed.
Patient case study - Patient with acute myocardial infarction
Disclaimer
How to use this case study
Rate this content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
- Patient case study - Patient with acute myocardial infarction
- Disclaimer
- How to use this case study
- Login or create an account to see restricted contentMohammed
- Login or create an account to see restricted contentAdmission to the ER
- Login or create an account to see restricted contentInitial management in the ER
- Login or create an account to see restricted contentFurther investigations
- Login or create an account to see restricted contentDiagnosing T2D after acute STEMI
- Login or create an account to see restricted contentDiagnosing T2D after acute STEMI
- Login or create an account to see restricted contentDiagnosing T2D after acute STEMI
- Login or create an account to see restricted contentSuspicion for T2D on presentation with an acute STEMI
- Login or create an account to see restricted contentSuspicion for T2D on presentation with an acute STEMI
- Login or create an account to see restricted contentPreviously unknown diabetes in patients presenting with acute MI is under-recognised and undertreated
- Login or create an account to see restricted contentMohammed’s blood test results
- Login or create an account to see restricted contentMohammed’s blood test results
- Login or create an account to see restricted contentMohammed’s results suggest that he has T2D
- Login or create an account to see restricted contentDiscussion with Mohammed
- Login or create an account to see restricted contentHaving diabetes and prior MI is associated with a near 4-fold increased risk of death compared with not having these conditions
- Login or create an account to see restricted contentFirst-line treatment approach for T2D
- Login or create an account to see restricted contentFirst-line treatment approach for T2D
- Login or create an account to see restricted contentFirst-line treatment approach for T2D
- Login or create an account to see restricted contentConfirming treatment approach for T2D
- Login or create an account to see restricted contentTarget for glycaemic control
- Login or create an account to see restricted contentTarget for glycaemic control
- Login or create an account to see restricted contentDiscussion with Mohammed
- Login or create an account to see restricted contentTreatment prescribed at discharge
- Login or create an account to see restricted contentDischarge from hospital
- Login or create an account to see restricted contentMohammed – 8 weeks later
- Login or create an account to see restricted contentMohammed’s management plan for T2D
- Login or create an account to see restricted contentMohammed’s management plan for T2D
- Login or create an account to see restricted contentMohammed’s management plan for T2D
- Login or create an account to see restricted contentMohammed’s management plan for T2D
- Login or create an account to see restricted contentMohammed’s management plan for T2D
- Login or create an account to see restricted contentESC guidelines recommend glucose‑lowering therapies with proven CV benefit in patients with ASCVD or very high/high CV risk
- Login or create an account to see restricted contentESC guidelines recommend glucose‑lowering therapies in patients with diabetes at very high CV risk and HF risk
- Login or create an account to see restricted contentADA standards recognise HF as an important type of CV disease to consider when determining optimal T2D treatment
- Login or create an account to see restricted contentADA recommends the use of an SGLT2 inhibitor or GLP-1 RA to reduce the risk of CV events or CKD progression
- Login or create an account to see restricted contentThe 2020 ACC ECDP discusses opportunities to initiate SGLT2 inhibitors or GLP-1 RAs with demonstrated CV or kidney benefits in patients with T2D
- Login or create an account to see restricted contentThe 2020 ACC ECDP recommends the use of SGLT2 inhibitors or GLP-1 RAs with proven CV benefit in conjunction with guideline-directed medical therapy
- Login or create an account to see restricted contentThe 2020 ACC ECDP discusses using an SGLT2 inhibitor to manage patients with T2D at risk of developing ASCVD, HF and DKD
- Login or create an account to see restricted contentDiscussion
- Login or create an account to see restricted contentMohammed – patient case learning points